why choose us

Clinical Trials Search

Showing 10,510 of 132,366 result(s)
A Study of DB-1311 in Advanced;Metastatic Solid Tumors

Status: Completed

Condition: Advanced Solid Tumors

Interventions: Administered I.V.

Date: 2023-06-13

Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry

Status: Completed

Condition: Otitis Media With Effusion

Interventions: Iontophoretic delivery of TYMBION™ otic anesthetic using the Tula Iontophoresis System and tube insertion using the Tula Tube Delivery System

Date: 2023-06-13

Developing a mHealth Simulation Platform for Youth

Status: Completed

Condition: Engagement, Patient

Interventions: diabetes self-management and diabetes technology education software

Date: 2023-06-13

Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration

Status: Completed

Condition: Chronic Pain

Interventions: secures SCS trial leads with a suture

Date: 2023-06-13

Sponsor-Initiated OCS Heart Perfusion Registry

Status: Completed

Condition: Heart Transplant

Interventions:

The TransMedics® OCS Heart System is a portable system available for ex-vivo maintenance of a donor heart in a metabolically active and beating sta

Date: 2023-06-13

HIIT Following Breast Cancer Chemotherapy

Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Interventions: Research participants will be randomly assigned to either high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), or t

Date: 2023-06-13

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Status: NOT_YET_RECRUITING

Condition: Sickle Cell Disease

Interventions: Fostamatinib will be administered orally, at a dose of 100 mg twice a day for 14 days and if tolerated, will be escalated to a dose of 150 mg, orally,

Date: 2023-06-13

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

Status: NOT_YET_RECRUITING

Condition: Metastatic Nasopharyngeal Carcinoma

Interventions: Undergo collection of blood samples

Date: 2023-06-13

A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation

Status: Completed

Condition: COVID-19

Interventions: 200 ml of COVID Convalescent Plasma at +14 days, +28 days, +2 months, and +3 months following hematopoietic stem cells transplantation.

Date: 2023-06-13